Pelletization of melts and liquids
Authors:
Miloslava Rabišková
Authors place of work:
Veterinární a farmaceutická univerzita Brno, Farmaceutická fakulta, Ústav technologie léků
Published in the journal:
Čes. slov. Farm., 2011; 60, 54-60
Category:
Review Articles
Summary
During the second half of the last century, pelletization methods based on wetting were developed, e.g. agglomeration in coating pans, pelletization plates or fluid-bed equipment, layering of the drug in solution or suspension on inactive spherical cores, extrusion/spheronization and later on also rotoagglomeration in rotogranulators or rotoprocessors. These technologies have become a requisite part of industrial production of solid dosage forms. At present, numerous experimental papers deal with pellet preparation from melts and liquids. These new pelletization methods are the topic of the present article. Pellet preparation from melts is represented by three methods, i.e. fluid hot melt agglomeration, hot melt extrusion, and freeze pelletization. Jet cutting and cryopelletization are the techniques dealing with pellet preparation from liquids.
Key words:
fluid hot melt agglomeration – hot melt extrusion – freeze pelletization – jet cutting – cryopelletization
Zdroje
1. Jones, D. M.: Air suspension coating. In: Swarbrick, J., Boylan, J. C. eds. Encyclopedia of Pharmaceutical Technology, Vol. 1. New York: Marcel Dekker 1988; 188–216.
2. Ghebre-Sellassie, I.: A general overview. In: Ghebre-Sellassie, I. ed. Pharmaceutical Pelletization Technology. New York: Marcel Dekker 1989; 1–13.
3. Goodhart, F. W.: Centrifugal equipment. In: Ghebre-Sellassie, I. ed. Pharmaceutical Pelletization Technology. New York: Marcel Dekker 1989; 101–122.
4. Häring, A., Vetchý, D., Janovská, L., Krejčová, K., Rabišková, M.: Differences in characteristics of pellets prepared by different pelletization methods. Drug Dev. Ind. Pharm. 2008; 34, 289–296.
5. Zhai, H., Andrews, G., Jones, D., Bell, S., Walker, G. M.: Nucleation and growth in fluidised hot melt granulation. Powder Technol. 2009; 189, 230–237.
6. Walker, G. M., Andrews, G., Jones, D.: Effect of proces parameters on the melt granulation of pharmaceutical powders. Powder Technol. 2006; 165, 161–166.
7. Crowley, M. M., Zhang, F., Repka, M. A., Thumma, S., Upadhye, S. B., Battu, K. S., McGinity, J. W., Martin, C.: Pharmaceutical application of hot-melt extrusion: Part I. Drug Dev. Ind. Pharm. 2007; 33, 909–926.
8. McGinity, J. W.: Melt-extruded controlled release dosage forms. In: Ghebre-Sellassie, I. ed. Pharmaceutical Extrusion Technology. New York: Marcel Dekker 2003; 183–208.
9. Repka, M. A., Gerding, T. G., Repka, S. l., McGinity, J. W.: Influence of plasticizers and drugs on the physical-mechanical properties of hydroxypropylcellulose films prepared by hot melt extrusion. Drug Dev. Ind. Pharm. 1999; 25, 625–633.
10. Aitken-Nichol, C., Zhang, F., McGinity, J. W.: Hot melt extrusion of acrylic films. Pharm. Res. 1996; 13, 804–808.
11. Crowley, M. M., Zhang, F., Koleng, J. J., McGinity, J. W.: Stability of polyethylene oxide in matrix tablets prepared by hot-melt extrusion. Biomaterials 2002; 23, 4241–4248.
12. Wu, C. M. J.: Influence of methyl paraben as solid state plasticizer on the physicochemical properties of Eudragit RS PO hot-melt extrudates. J. Pharm. Biopharm. 2003; 56, 95–100.
13. Sekiguchi, K., Obi, N.: Studies on absorption of eutectic mixtures. 1. A comparison of the behaviour of eutectic mixtures of sulfathiazole and that of ordinary sulfathiazole in man. Chem. Pharm. Bull. 1961; 9, 866–872.
14. Hajratwala, B. R.: Dissolution of solid dispersion systems. Aust. J. Pharm. Sci. 1974; 4, 101–109.
15. Breitenbach, J., Magerlein, M.: Melt-extruded molecular dispersions. In: Ghebre-Sellassie, I. ed. Pharmaceutical Extrusion Technology. New York: Marcel Dekker 2003; 245–260.
16. Dyar, S. C., Mollan, M.: Melt-extruded particulate dispersions. In: Ghebre-Sellassie, I. ed. Pharmaceutical Extrusion Technology. New York: Marcel Dekker 2003; 261–275.
17. Repka, M. A., Battu, S. K., Upadhye, S. B., Thumma, S., Crowley, M. M., Zhang, F., Martin, C., McGinity, J. W.: Pharmaceutical applications of hot-melt extrusion: Part II. Drug Dev. Ind. Pharm. 2007; 33, 1043–1057.
18. European Patent 0003612, 1999.
19. Elliot, B.: Film, sheet and laminates. In: Ghebre-Sellassie, I. ed. Pharmaceutical Extrusion Technology. New York: Marcel Dekker 2003; 225–244.
20. Repka, M. A., Gutta, K., Prodduturi, S., Munjal, M., Stodghill, S. P.: Characterization of cellulosic hot-melt extruded films containing lidocaine. Eur. J. Pharm. Biopharm. 2005; 59, 189–196.
21. Repka, M. A., Mididoddi, P. K., Stodghill, P.: Influence of etching on humans nails for the assessment of treatment modalities for onchomycosis, Int. J. Pharm. 2004; 283, 95–106.
22. Repka, M. A., Gerding, T. G., Repka, S. L., McGinity, J. W.: Influence of plasticizers and drugs on the physical-mechanical properties of hydroxypropylcellulose films prepared by hot melt extrusion. Drug Dev. Ind. Pharm. 1999; 25, 625–633.
23. Crowley, M. M., Fredersdorf, A., Schroeder, B., Ucera, S., Prodduturi, S., Repka, M. A.: The influence of guaifenesin and ketoprofen on the properties of hot-melt extruded polyethylene oxide films. Eur. J. Pharm. Sci. 2004; 22, 409–418.
24. Repka, M. A., McGinity, J. W.: Influence of vitamin E TPGS on the properties of hydrophilic films produced by hot-melt extrusion. Int. J. Pharm. 2000; 202, 63–70.
25. Podduturi, S., Manek, R. V., Kolling, W. M., Stodghill, S. P., Repka, M. A.: Water vapor sorption isotherms of hot-melt extruded hydroxypropylcellulose films: Effects on physico-mechanical properties, release characteristics and stability. J. Pharm. Sci. 2004; 93, 3047–3056.
26. Podduturi, S., Manek, R. V., Kolling, W. M., Stodghill, S. P., Repka, M. A.: Solid state stability and characterization of hot-melt extruded poly (ethylene oxide) films. J. Pharm. Sci. 2005; 94, 2232–2245.
27. Repka, M. A., Prodduturi, S., Stodghill, S. P.: Production and characterisation of hot-melt extruded films containing clotrimazole. Drug Dev. Ind. Pharm. 2003; 29, 757–765.
28. Rothen-Weinhold, A., Oudry, N., Schwach-Abdellaoui, K., Frutiger-Hughes, S., Hughes, G. J., Jeannerat, D.: Formation of peptide impurities in polyester matrices during implant manufacturing. Eur. J. Pharm. Sci. 2000; 49, 253–257.
29. Van Laarhoven, J. A. H., Kruft, M. A. B., Vromans, H.: In vitro release properties of ethonorgestrel and ethinyl estradiol from a contraceptive vaginal ring. Int. J. Pharm. 2002; 232, 163–173.
30. Cheboyina, S., O’Haver, J., Wyandt, C. M.: A mathematical model to predict the size of the pellets formed in freeze pelletization techniques: Parameters affecting pellet size. J. Pharm. Sci. 2006; 95, 167–180.
31. Cheboyina, S., Wyandt, C. M.: Wax-based sustained release matrix pellets prepared by a novel freeze pelletization technique. I. Formulation and proces variables affecting pellet characteristics. Int. J. Pharm. 2008; 359, 158–166.
32. Cheboyina, S., Wyandt, C. M.: Wax-based sustained release matrix pellets prepared by a novel freeze pelletization technique. II. In vitro drug release studies and release mechanisms. Int. J. Pharm. 2008; 359, 167–173.
33. Rowe, R. C., Sheskey, P., Owen, S. C.: Handbook of Pharmaceutical Excipients. 5th ed., London: Pharmaceutical Press 2006; 231–233.
34. Rowe, R. C., Sheskey, P., Owen, S. C.: Handbook of Pharmaceutical Excipients. 5th ed., London: Pharmaceutical Press 2006; 447–448.
35. Vorlop, K. D., Klein, J.: New developments in the field of cell immobilization: formation of biocatalysts by inotropic gelation. In: Lafferty, R. M. ed. Enzyme Technology. Berlin: Springer 1983; 219–235.
36. Brandenberger, H., Widmer, F.: A new multinozzle encapsulation/ immobilisation system. In: Godia, F., Poncelet, D. eds. Proceedings of the International Workshop Bioencapsulation VI. Barcelona: 1997; poster 9.
37. Case, C. C.: Melt pelletization. In: Ghebre-Sellasie, I. ed. Pharmaceutical Extrusion Technology, New York: Marcel Dekker 2005; 171–182.
38. Jahnz, U., Wittlich, P., Prusse, U., Vorlop, K.-D.: New matrices and bioencapsulation proces. In: Hofman, M., Thonart, P. eds. Engineering and Manufacturing for Biotechnology, Holandsko: Kluwer Academic Publishers 2001; 293–307.
39. Prusse, U., Bruske, F., Breford, J., Vorlop, K.-D.: Improvement of the Jet Cutting method for the production of spherical particles from viscous polymer solutions. Chem. Eng. Technol. 1998; 21, 153–157.
40. Smidsrod, V., Skjak-Braek, G.: Alginate as immobilisation matrix for cells. Trends Biotechnol. 1990; 8, 71–78.
41. Berger, R., Ruhlemann, I.: Stable inotropic gel for cell immobilization using high molecular weight pectic acid. Acta Biotechnol. 1988; 8, 401–405.
42. Chibata, I., Tosa, T., Sato, T., Takata, I.: Immobilisation of cells in carageenan. Methods Enzymol. 1987; 135, 189–198.
43. Vorlop, K.-D., Klein, J.: Entrapment of microbial cells in chitosan. Methods Enzymol. 1987; 135, 259–268.
44. Muscat, A., Prusse, U., Vorlop, K.-D.: Stable support materials for the immobilisation of viable cells. In: Wijffels, R. H., Buitelaar, R. M., Bucke, C., Tramper, J. eds. Immobilised cells: Basic and Applications. Elsevier Sciences B. V. 1998; 55–61.
45. Emori, H., Mikawa, K., Hamaya, M., Yamaguche, T., Tanaka, K., Takeshima, T.: PEGASUS Innovative biological nitrogen removal proces using entrappedt nitrifiers. In: Wijffels, R. H., Buitelaar, R. M., Bucke, C., Tramper, J. eds. Immobilised cells: Basic and Applications. Elsevier Sciences B. V. 1998; 85–97.
46. Lozinsky, V. I., Plieva, F. M.: Poly(vinyl alcohol) cryogels employed as matrices for cell immobilisation. Rnzyme Microbiol. Technol. 1998; 23, 227–242.
47. Knoch, A.: Cryopelletization. In: Ghebre-Sellasssie, I. ed. Multiparticulate Oral Drug Delivery. New York: Marcel Dekker 1994; 35–49.
Štítky
Pharmacy Clinical pharmacologyČlánok vyšiel v časopise
Czech and Slovak Pharmacy
2011 Číslo 2
Najčítanejšie v tomto čísle
- Generic substitution, replacement and substitution of drugs: contemporary extent
- Myasthenia gravis – current treatment standards and emerging drugs
- Bacteriocins produced by lactic acid bacteria
- Pelletization of melts and liquids